Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pratt

Showing results (701-710 of 752) with videos related to

Pageof 76
Sort By:
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
The Journal of Molecular Diagnostics : JMD|February 8, 2022
CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative ProjectAndrea Gaedigk, Erin C Boone, Steven E Scherer, et al.
The American Journal of Cardiology|December 17, 1997
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)P H Stone, B R Chaitman, S Forman, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2012
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular PathologyIris Schrijver, Nazneen Aziz, Daniel H Farkas, et al.
Immunity|May 27, 2025
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironmentWilliam D Green, Amber Gomez, Alec L Plotkin, et al.
The Journal of Molecular Diagnostics : JMD|September 22, 2009
Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testingShannon D Barker, Sherri Bale, Jessica Booker, et al.
The Pharmacogenomics Journal|September 9, 2023
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trialMichael T Eadon, Marc B Rosenman, Pengyue Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microgliaJasmin S Revanna, Karl Wessendorf-Rodriguez, Qiang Xiao, et al.
Pageof 76

Showing results (701-710 of 752) with videos related to

Sort By:
Pageof 76
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for <i>APOL1, NAT2,</i> and <i>YEATS4</i> Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
The Journal of Molecular Diagnostics : JMD|February 8, 2022
CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative ProjectAndrea Gaedigk, Erin C Boone, Steven E Scherer, et al.
The American Journal of Cardiology|December 17, 1997
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)P H Stone, B R Chaitman, S Forman, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2012
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular PathologyIris Schrijver, Nazneen Aziz, Daniel H Farkas, et al.
Immunity|May 27, 2025
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironmentWilliam D Green, Amber Gomez, Alec L Plotkin, et al.
The Journal of Molecular Diagnostics : JMD|September 22, 2009
Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testingShannon D Barker, Sherri Bale, Jessica Booker, et al.
The Pharmacogenomics Journal|September 9, 2023
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trialMichael T Eadon, Marc B Rosenman, Pengyue Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microgliaJasmin S Revanna, Karl Wessendorf-Rodriguez, Qiang Xiao, et al.
Pageof 76